top of page

ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial

Product details

Registration number: SIN14532P

Classification: Prescription Only

Active ingredients: Paclitaxel

Strength: 100mg/vial

Dosage form: INJECTION, POWDER, FOR SUSPENSION

Route: INTRAVENOUS DRIP

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

ATC code: L01CD01

HSA approval date: 31 March 2014

Manufacturer(s):

  • Abraxis BioScience, LLC
  • Baxter Oncology GmbH

Manufacturing country/countries: UNITED STATES; GERMANY

What are the HSA registration number and classification for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14532P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Paclitaxel

Strength: 100mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SUSPENSION

Route: INTRAVENOUS DRIP

Source for this answer

Who is the recorded registrant for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?

According to the HSA dataset updated 7 August 2026:

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Abraxis BioScience, LLC
  • Baxter Oncology GmbH

Manufacturing country/countries: UNITED STATES; GERMANY

Source for this answer

Where can I look up ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14532P or the exact product name ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial. The general register link does not preselect this product.

Source for this answer

What are the source dates for this ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14532P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page